-
Dermatologic Therapy Mar 2019
Topics: Antifungal Agents; Humans; Male; Middle Aged; Mycoses; Potassium Iodide; Treatment Outcome
PubMed: 30637881
DOI: 10.1111/dth.12819 -
American Journal of Ophthalmology Jul 1970
Topics: Drug Synergism; Humans; Keratitis; Mycoses; Natamycin; Potassium Iodide; Solutions
PubMed: 5310297
DOI: 10.1016/0002-9394(70)90687-2 -
Dermatologic Therapy Jan 2022
Repurposing super saturated potassium iodide as an adjunctive treatment in mucormycosis: An exposition in a diabetic patient with rhino-orbital disease with cutaneous extension.
Topics: Antifungal Agents; Diabetes Mellitus; Humans; Mucormycosis; Orbital Diseases; Potassium Iodide
PubMed: 34708500
DOI: 10.1111/dth.15181 -
Journal of Endocrinological... Feb 2009
Clinical dilemmas arising from the increased intake of iodine in the Spanish population and the recommendation for systematic prescription of potassium iodide in pregnant and lactating women (Consensus of the TDY Working Group of SEEN).
Topics: Deficiency Diseases; Female; Humans; Infant; Infant, Newborn; Iodine; Lactation; Potassium Iodide; Pregnancy; Spain
PubMed: 19411820
DOI: 10.1007/BF03345711 -
World Journal of Surgery Oct 2020Potassium iodide (KI) treatment affects the vascularity of the thyroid gland and therefore may improve intraoperative visualization of essential structures. However,...
BACKGROUND
Potassium iodide (KI) treatment affects the vascularity of the thyroid gland and therefore may improve intraoperative visualization of essential structures. However, clear evidence for its usage is lacking, and its implementation in patients suffering from Graves' disease is becoming rare. The objective of this retrospective study was to assess the impact of KI treatment on the intraoperative course and the outcome of patients undergoing thyroidectomy for Graves' diseases.
METHODS
The study included 442 patients: 125 patients (28.3%) who received a preoperative treatment with KI ("Group KI") and 317 patients (71.7%) without a KI therapy ("Group No-KI"). Indication for KI treatment was a thyroid bruit (82.5%), as well as hyperthyroidism refractive to medical treatment with antithyroid drugs (17.4%).
RESULTS
All patients underwent total thyroidectomy. Permanent vocal cord paresis and permanent hypoparathyroidism were similar in both groups. KI treatment was associated with a significantly longer operative time (142 vs. 128 min, p < 0.001) and a significant higher weight of the thyroid gland. KI treatment did not impact duration of hospital stay or occurrence of secondary hemorrhage.
CONCLUSIONS
The complication rate of this study population with clinically severe GD was very low-which may be caused by pre-treatment of patients. The complementary option of a potassium iodide treatment before surgery remains a possibility and should be implemented individually.
Topics: Adolescent; Adult; Age Distribution; Aged; Aged, 80 and over; Child; Female; Graves Disease; Humans; Hypoparathyroidism; Male; Middle Aged; Operative Time; Postoperative Complications; Potassium Iodide; Preoperative Care; Retrospective Studies; Thyroidectomy; Treatment Outcome; Vocal Cord Paralysis; Young Adult
PubMed: 32447416
DOI: 10.1007/s00268-020-05593-0 -
Science (New York, N.Y.) Oct 1982
Topics: Child; Female; Humans; Iodine Radioisotopes; Nuclear Reactors; Potassium Iodide; Pregnancy; Thyroid Gland; United States; United States Food and Drug Administration
PubMed: 7123219
DOI: No ID Found -
British Medical Journal Oct 1980
Topics: Humans; Iodine Radioisotopes; Neoplasms, Radiation-Induced; Nuclear Reactors; Potassium Iodide; Thyroid Gland; Thyroid Neoplasms
PubMed: 7427554
DOI: 10.1136/bmj.281.6246.988 -
Methods in Molecular Biology (Clifton,... 2022The current increase in antibiotic resistance worldwide and the emergence of microbial strains that are resistant to all known antibiotics have stimulated research into...
The current increase in antibiotic resistance worldwide and the emergence of microbial strains that are resistant to all known antibiotics have stimulated research into novel strategies such as aPDI that are thought to be unlikely to lead to the development of resistance. Although many studies have reported in vitro aPDI killing of microorganisms by a range of different photosensitizers, there are still limitations to the effectiveness of aPDI, and recurrence of bacterial growth may occur in animal studies after completion of the illumination. In this chapter we cover a novel and relatively simple method to improve the efficacy of aPDI against Gram-positive Staphylococcus aureus, Gram-negative Escherichia coli, and fungal yeast Candida albicans by the addition of potassium iodide, a nontoxic inorganic salt. Under some circumstances up to six-logs additional killing can be obtained.
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Escherichia coli; Photosensitizing Agents; Potassium Iodide
PubMed: 35505037
DOI: 10.1007/978-1-0716-2099-1_32 -
Journal of the American Academy of... Jul 1983Potassium iodide therapy has a history of more than 150 years. It has been tried in many diseases in the past. However, with the development of modern medications...
Potassium iodide therapy has a history of more than 150 years. It has been tried in many diseases in the past. However, with the development of modern medications indications for potassium iodide therapy are very limited. It is well known that potassium iodide is the drug of choice for sporotrichosis. Subacute nodular migratory panniculitis and erythema nodosum have also been treated successfully with this drug.
Topics: Erythema Multiforme; Erythema Nodosum; Humans; Neutrophils; Potassium Iodide; Skin Diseases; Syndrome; Vasculitis, Leukocytoclastic, Cutaneous
PubMed: 6886108
DOI: 10.1016/s0190-9622(83)70110-6 -
Pediatric Dermatology Mar 2018We describe a 5-month-old boy with clinical and histopathologic presentation of Sweet syndrome. He responded to systemic corticosteroids, with multiple flares on...
We describe a 5-month-old boy with clinical and histopathologic presentation of Sweet syndrome. He responded to systemic corticosteroids, with multiple flares on tapering; potassium iodide was added, which provided complete resolution of Sweet syndrome. Potassium iodide has been used in only a few cases, and no standard dosage has been established in children. We discuss calculation of a pediatric dosage for potassium iodide in Sweet syndrome.
Topics: Glucocorticoids; Humans; Infant; Male; Potassium Iodide; Recurrence; Skin; Sweet Syndrome; Treatment Outcome
PubMed: 29314271
DOI: 10.1111/pde.13391